- Nachrichtendetail
-
09.07.2024 17:00:16 - dpa-AFX: Pfizer Chief Scientific Officer Mikael Dolsten To Step Down
NEW YORK CITY (dpa-AFX) - Pfizer Inc. (PFE), Tuesday announced that Mikael
Dolsten will step down from the role of Chief Scientific Officer, and President,
Pfizer Research & Development.
The drug manufacturer also stated that Dolsten will continue to serve in his
current position until a successor is appointed.
To identify a new chief scientific officer, Pfizer will initiate an external
search which is expected to last through early next year.
Currently, Pfizer's stock is moving down 1.84 percent, to $ 27.42 on the New
York Stock Exchange.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
Dolsten will step down from the role of Chief Scientific Officer, and President,
Pfizer Research & Development.
The drug manufacturer also stated that Dolsten will continue to serve in his
current position until a successor is appointed.
To identify a new chief scientific officer, Pfizer will initiate an external
search which is expected to last through early next year.
Currently, Pfizer's stock is moving down 1.84 percent, to $ 27.42 on the New
York Stock Exchange.
Copyright(c) 2024 RTTNews.com. All Rights Reserved
Copyright RTT News/dpa-AFX
| Name | WKN | Börse | Kurs | Datum/Zeit | Diff. | Diff. % | Geld | Brief | Erster | Schluss | |
|---|---|---|---|---|---|---|---|---|---|---|---|
 |
PFIZER INC. DL-,05 | 852009 | Frankfurt | 27,060 | 23.07.24 17:21:26 | -0,140 | -0,51% | 27,090 | 27,100 | 27,200 | 27,200 |
